Quality of Life of Patients With a History of Drug Allergy in Thailand

This study is currently recruiting participants.
Verified November 2013 by Chulalongkorn University
Sponsor:
Collaborators:
Mahidol University
Phramongkutklao College of Medicine
Information provided by (Responsible Party):
Jettanong Klaewsongkram, Chulalongkorn University
ClinicalTrials.gov Identifier:
NCT01666470
First received: August 12, 2012
Last updated: November 24, 2013
Last verified: November 2013
  Purpose

Quality of life of patients with a history of drug allergy in Thailand will be studied.


Condition Intervention
Quality of Life
Other: Questionnaires

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Quality of Life of Patients With a History of Drug Allergy in Thailand

Resource links provided by NLM:


Further study details as provided by Chulalongkorn University:

Primary Outcome Measures:
  • The quality of life of Thai patients with a history of drug allergy evaluating by DrHy-Q (Thai version) [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • The correlation between DrHy-Q (Thai version) and WHOQOL-BREF-THAI [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    Pearson correlation coefficient between scores from DrHy-Q (Thai version) and WHOQOL-BREF-THAI in patients with a history of drug allergy will be analyzed.


Estimated Enrollment: 400
Study Start Date: August 2012
Estimated Study Completion Date: September 2014
Estimated Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Drug allergy patients
Patients with a history of drug allergy in Thailand
Other: Questionnaires
DrHy-Q (Thai version) and WHOQOL-BREF-THAI will be asked

Detailed Description:

Thai patients with a history of drug allergy will be evaluated for their quality of life based on drug hypersensitivity quality of life questionnaire (DrHy-Q; Thai version) and The World Health Organization Quality of Life instrument (WHOQOL-BREF-THAI)

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Thai patients with a history of drug allergy

Criteria

Inclusion Criteria:

  • Have a history of drug allergy
  • At least 18 years of age

Exclusion Criteria:

  • Not be able to understand Thai language
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01666470

Contacts
Contact: Jettanong Klaewsongkram, MD 662-2564152 Jettanong.K@chula.ac.th

Locations
Thailand
Faculty of Medicine, Chulalongkorn University Recruiting
Bangkok, Thailand, 10330
Contact: Jettanong Klaewsongkram, MD    662-2564152    Jettanong.K@chula.ac.th   
Principal Investigator: Jettanong Klaewsongkram, MD         
Faculty of Medicine, Siriraj Hospital, Mahidol University Recruiting
Bangkok, Thailand
Contact: Torpong Thongngarm, MD    662-4198263      
Principal Investigator: Torpong Thongngarm, MD         
Faculty of Medicine, Ramathibodi Hospital, Mahidol University Recruiting
Bangkok, Thailand
Contact: Ticha Rerkpattanapipat, MD    662-2011477      
Principal Investigator: Ticha Rerkpattanapipat, MD         
Phramongkutklao College of Medicine Recruiting
Bangkok, Thailand
Contact: Atik Sangasapaviliya, MD    662-3549085      
Principal Investigator: Atik Sangasapaviliya, MD         
Sponsors and Collaborators
Chulalongkorn University
Mahidol University
Phramongkutklao College of Medicine
Investigators
Principal Investigator: Jettanong Klaewsongkram, MD Chulalongkorn University
  More Information

Additional Information:
No publications provided

Responsible Party: Jettanong Klaewsongkram, Head of Division of Allergy and Clinical Immunology, Department of Medicine, Chulalongkorn University
ClinicalTrials.gov Identifier: NCT01666470     History of Changes
Other Study ID Numbers: Chula-ARC 001/12
Study First Received: August 12, 2012
Last Updated: November 24, 2013
Health Authority: Thailand: Ethical Committee

Keywords provided by Chulalongkorn University:
Quality of life

Additional relevant MeSH terms:
Drug Hypersensitivity
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on April 15, 2014